Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Recruiting
Phase 1
Phase 2
Interventional Study
Autoimmune Diseases
Cardiovascular Disorders
Diabetes Complications
Integumentary Disease
Musculoskeletal Disorders
Neurodegenerative Disorders
Neurologic Disorders
Pulmonary Disorders
Sexual Dysfunction
Urologic Disorders
Viral Illness
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 5,000 (estimated)
- Sponsor
- Thomas Advanced Medical LLC · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 and older
* Ability to provide informed consent
* Availability for follow up visits
Exclusion Criteria:
* Active or recent malignancy (within last 2 years)
* Pregnancy or breast-feeding
* Inability to provide informed consent
Contacts